Minerva Surgical Inc. v. Hologic Inc.
Issues
When a party transfers a patent to a third party and the third party later sues the transferring party for patent infringement, can the transferring party claim the patent is invalid?
This case asks the Supreme Court to rule on the validity of the assignor estoppel doctrine. Under this doctrine, an assignor of a patent may not, in a suit against the assignee, claim that the patent is invalid. Petitioner Minerva Surgical Inc. argues assignor estoppel is not supported in the Patent Act and Court precedent favors the doctrine’s abolition. Respondent Hologic Inc. counters that assignor estoppel is implicit in the Patent Act and that stare decisis dictates that the Court uphold assignor estoppel. The outcome of this case has significant policy implications regarding the proper balance of the public interest in challenging potentially invalid patents and the interest in promoting equity and fair dealing in the assignor–assignee relationship.
Questions as Framed for the Court by the Parties
Whether a defendant in a patent infringement action who assigned the patent, or is in privity with an assignor of the patent, may have a defense of invalidity heard on the merits.
This case involves U.S. Patents Nos. 6,782,183 (“’183 patent”) and 9,095,348 (“’348 patent”). Hologic, Inc. v. Minerva Surgical at 1260. Both patents lay claim to various devices and procedures related to endometrial ablation treatment, which are used to treat abnormally heavy menstrual bleeding. Id. at 1260–61. Csaba Truckai is listed as the inventor of both patents.
Edited by
Additional Resources
- Christina Sperry & Monique Winters Macek, Doctrine of Assignor Estoppel to be Reviewed by U.S. Supreme Court, National Law Review (Feb. 25, 2021).
- Eileen McDermott, Supreme Court Will Review Doctrine of Assignor Estoppel, IPWatchdog (Jan. 11, 2021).